Ramipril
Ace Inhibitors, Plain
Sold as ALTACE · ALTACE HCT
- Drug class
- Ace Inhibitors, Plain
- Availability
- Prescription only
- Routes
- Oral
- Markets covered
- 3
- Products on record
- 199
- FDA reports (12 mo)
- 6,129
Overview
Plain-language summary, compiled from the cited regulatory records
Ramipril is a medication classified as an ACE inhibitor [1]. It is approved for treating hypertension, also known as high blood pressure. Ramipril can be used as a standalone treatment or in combination with thiazide diuretics for managing hypertension [1].
Additionally, ramipril is indicated for patients with stable congestive heart failure who have experienced post-myocardial infarction symptoms [1]. In the past 12 months, there have been 6,129 adverse event reports associated with ramipril [2]. Common reasons cited in these reports include off-label use, pain, perceived drug ineffectiveness, vomiting, and nausea [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 102 | May 29, 2026 |
| CA Canada | Health Canada | 94 | April 17, 2026 |
| US United States | FDA | 3 | April 14, 2025 |
GBUnited Kingdom· MHRA
102 products
Uses
Treatment of hypertension. 1). 1). - Treatment of symptomatic heart failure. - Secondary prevention after acute myocardial infarction: reduction of mortality from the acute phase of myocardial infarction in patients with clinical signs of heart failure when started > 48 hours following acute myocardial infarction.
How to take
CACanada· Health Canada
94 products
Uses
ALTACE HCT (ramipril/hydrochlorothiazide) is indicated for the treatment of essential hypertension in patients for whom this combination therapy is appropriate. ALTACE HCT is not indicated for initial therapy (see 4 DOSAGE AND ADMINISTRATION).
Patients in whom ramipril and diuretic are initiated simultaneously can develop symptomatic hypotension. Patients should be titrated on individual drugs. If the fixed combination represents the dose and dosing frequency determined by this titration, the use of ALTACE HCT may be more convenient in the management of patients.
If during maintenance therapy dosage adjustment is necessary, it is advisable to use the individual drugs. 1 Pediatrics Pediatrics (<18 years of age): The safety and effectiveness of ALTACE HCT in pediatric patients have not been established.
Therefore, ALTACE HCT is not indicated in this patient population. 4 Geriatrics).
USUnited States· FDA
3 products
Uses
1. INDICATIONS AND USAGE • Ramipril capsules USP are indicated for the treatment of hypertension. It may be used alone or in combination with thiazide diuretics. 1 ). 3 ). 1 Hypertension Ramipril capsules USP are indicated for the treatment of hypertension.
It may be used alone or in combination with thiazide diuretics. 3 Heart Failure Post-Myocardial Infarction Ramipril capsules USP are indicated in stable patients who have demonstrated clinical signs of congestive heart failure within the first few days after sustaining acute myocardial infarction.
3 ) ].
How to take
Drug interactions
Known interactions involving Ramipril. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 600. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL004270299 · revised August 22, 2025
- [2]Health Canada (DPD) · 02283158 · revised September 19, 2025
- [3]FDA DailyMed · 01da05d8-e72e-42… · revised July 1, 2022 [PDF]
- [4]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.